Table 3 LncRNA expression in malignant (n = 30) versus benign (n = 21) IPMN cases.
LncRNA | Overall mean | Benign mean | Malignant mean | p value | False discovery rate | Fold Change |
|---|---|---|---|---|---|---|
GLIS3-AS1 | 11.7 | 10.6 | 12.4 | 0.005 | 0.120 | 1.2 |
ANRIL | 11.7 | 10.7 | 12.3 | 0.009 | 0.120 | 1.2 |
PANDA | 8.4 | 7.0 | 9.3 | 0.016 | 0.141 | 1.3 |
MEG3 | 10.3 | 9.4 | 10.9 | 0.022 | 0.141 | 1.2 |
PVT1 | 12.2 | 11.6 | 12.6 | 0.037 | 0.141 | 1.1 |
ADARB2-AS1 | 10.4 | 9.8 | 10.8 | 0.039 | 0.141 | 1.1 |
LINC00472 | 10.4 | 9.6 | 10.9 | 0.039 | 0.141 | 1.1 |
UCA1 | 12.1 | 11.4 | 12.6 | 0.041 | 0.141 | 1.1 |
PPP3CB | 13.5 | 13.1 | 13.8 | 0.058 | 0.176 | 1.1 |
LINC00469 | 9.6 | 8.7 | 10.3 | 0.099 | 0.277 | 1.2 |
LINC00491 | 9.9 | 9.2 | 10.5 | 0.133 | 0.337 | 1.1 |
TERC | 9.2 | 8.7 | 9.5 | 0.153 | 0.355 | 1.1 |
AS1DHRS4 | 13.4 | 13.0 | 13.7 | 0.183 | 0.365 | 1.0 |
MALAT1 | 10.7 | 10.4 | 11.0 | 0.198 | 0.365 | 1.1 |
H19 | 15.0 | 14.6 | 15.2 | 0.206 | 0.365 | 1.0 |
PTENP1 | 6.5 | 5.8 | 6.9 | 0.209 | 0.365 | 1.2 |
GAS5 | 15.2 | 14.9 | 15.4 | 0.240 | 0.379 | 1.0 |
HOXD-AS1 | 7.1 | 6.6 | 7.4 | 0.245 | 0.379 | 1.1 |
BCYRN1 | 0.2 | 0.4 | 0.1 | 0.336 | 0.506 | 0.1 |
HULC | 2.1 | 1.5 | 2.5 | 0.395 | 0.531 | 1.6 |
HOTAIR | 6.5 | 6.3 | 6.7 | 0.400 | 0.531 | 1.1 |
XIST | 0.9 | 0.7 | 1.1 | 0.537 | 0.683 | 1.6 |
LINC00244 | 0.9 | 0.7 | 1.0 | 0.594 | 0.690 | 1.4 |
SRA | 5.5 | 5.4 | 5.6 | 0.624 | 0.690 | 1.0 |
DDX6P | 2.9 | 2.6 | 3.1 | 0.632 | 0.690 | 1.2 |
lncRNA-p21 | 5.9 | 5.7 | 6.0 | 0.642 | 0.690 | 1.0 |
HOTTIP | 5.8 | 5.6 | 6.0 | 0.668 | 0.693 | 1.1 |
aHIF | 9.6 | 9.6 | 9.5 | 0.849 | 0.849 | 1.0 |
